Your browser doesn't support javascript.
loading
Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer.
Sharma, Mahesh C; Tuszynski, George P; Blackman, Marc R; Sharma, Meena.
Afiliação
  • Sharma MC; Research Service, Veterans Affairs Medical Center, Washington, DC 20422, USA; Department of Biochemistry and Molecular Medicine, George Washington University, Washington, DC, USA. Electronic address: Mahesh.Sharma@va.gov.
  • Tuszynski GP; Department of Neuroscience, Temple University School of Medicine, Philadelphia, PA 19140, USA.
  • Blackman MR; Research Service, Veterans Affairs Medical Center, Washington, DC 20422, USA; Department of Biochemistry and Molecular Medicine, George Washington University, Washington, DC, USA; Department of Medicine, George Washington University, Washington, DC, USA.
  • Sharma M; University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.
Cancer Lett ; 373(1): 27-35, 2016 Apr 01.
Article em En | MEDLINE | ID: mdl-26797420
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Anexina A2 / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Lett Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Anexina A2 / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Cancer Lett Ano de publicação: 2016 Tipo de documento: Article